Last updated on September 2020

A Study to Determine the Safety and Efficacy of Renexus in Macular Telangiectasia Type 2

Brief description of study

This study is a phase 3, randomized, multi-center study to evaluate the efficacy and safety of the Renexus implants in participants with macular telangiectasia type 2.

Clinical Study Identifier: NCT03319849

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.